Measles virus takes a two-pronged attack on PP1
1Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University Kita-ku, Kita-15, Nishi-7, Sapporo 060-8638, Japan.
Abstract:
During viral infection, RIG-I-like receptors (RLRs) are activated upon dephosphorylation by the phosphatase PP1, resulting in type I interferon production. In this issue, Davis et al. (2014) and Mesman et al. (2014) show that measles virus inhibits this antiviral response by targeting PP1 and thus preventing RLR dephosphorylation and activation.
Insights
Measles virus hinders the body's antiviral defenses by targeting protein phosphatase 1 (PP1). This prevents the activation of RIG-I-like receptors (RLRs), crucial for interferon production during viral infections.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- RIG-I-like receptors (RLRs) initiate antiviral responses.
- RLR activation requires dephosphorylation by protein phosphatase 1 (PP1).
- Type I interferons are key mediators of antiviral immunity.
Purpose of the Study:
- To investigate how measles virus interferes with the RLR-mediated antiviral pathway.
- To elucidate the mechanism by which measles virus evades host immune detection.
Main Methods:
- Cell-based assays to study RLR signaling.
- Analysis of protein-protein interactions between viral proteins and PP1.
- Measurement of interferon production in infected cells.
Main Results:
- Measles virus targets and inhibits PP1 activity.
- Inhibition of PP1 prevents RLR dephosphorylation and subsequent activation.
- This leads to suppressed type I interferon production, facilitating viral evasion.
Conclusions:
- Measles virus actively suppresses the innate immune system by targeting PP1.
- This viral strategy highlights a critical interaction between measles virus and host antiviral signaling pathways.
- Understanding this mechanism provides insights into viral pathogenesis and potential therapeutic targets.
